Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AMLBogdan Popescu, Catherine C. Smith|Cell Reports Medicine|2023Cited by 11
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid LeukemiaBogdan Popescu, Catherine C. Smith|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1